Volkmar Weissig is a Tenured Professor of Pharmacology and Pharmaceutical Sciences in the College of Pharmacy and a Professor of Biomedical Sciences in the College of Graduate Studies at Midwestern University. Dr. Weissig received his B.S., M.S. and Ph.D. degrees in Chemistry and his postdoctoral Sc.D. degree (“Habilitation”) in Biochemistry and Pharmaceutical Biotechnology from the Martin-Luther University in Halle (Germany). Combined he completed several years of postdoctoral fellowships at the Cardiology Research Center in Moscow (Russia), at the Academic Department of Medicine at the Royal Free Hospital School of Medicine in London (UK), at the Institute of Organic Chemistry at the Czechoslovakian Academy of Science in Prague (CSFR), at the College of Pharmacy and the College of Medicine at the University of Florida, Gainesville, FL and at Harvard Medical School and Massachusetts General Hospital in Boston, MA. Before joining the faculty at Midwestern University, Dr. Weissig was an Assistant Professor of Pharmaceutical Sciences at Northeastern University in Boston, MA.  Dr. Weissig holds 16 patents and has published over 120 research papers, review articles and book chapters, mostly in the area of nano drug delivery systems and mitochondrial medicine. He also edited and published 13 books. He serves as the Editor-in-Chief of the Journal of Liposome Research and he is member of several other Editorial Boards. In July 2009 he was inducted into the World Technology Network as a Fellow. Since October 2014 Dr. Weissig has been serving as the President of the World Mitochondria Society.